About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
19th Annual International Ultmann Chicago Lymphoma Symposium
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
P
Debate: We Should Stop Doing Autotransplants for Patients With MCL in 1st Remission
By
19th Annual International Ultmann Chicago Lymphoma Symposium
FEATURING
Patrick Stiff
By
19th Annual International Ultmann Chicago Lymphoma Symposium
FEATURING
Patrick Stiff
9 views
July 8, 2022
0 Comments
Login to view comments.
Click here to Login
Videos
15:36
19th Annual International Ultmann Chicago Lymphoma Symposium
Treatment of 1st Relapsed Classical Hodgkin Lymphoma
Feat.
V. Kenkre
12:39
19th Annual International Ultmann Chicago Lymphoma Symposium
Targeted Agents in Follicular Lymphoma: Small Molecules
Feat.
T. Phillips
19:06
19th Annual International Ultmann Chicago Lymphoma Symposium
Primary CNS Lymphoma: Focus on Consolidation
Feat.
T. Batchelor
20:01
19th Annual International Ultmann Chicago Lymphoma Symposium
CAR T-Cell Constructs in Lymphoma: Current and Future Options
Feat.
T. Siddiqi
54:37
19th Annual International Ultmann Chicago Lymphoma Symposium
Toxicities Associated With Chronic Therapies for Lymphoma: Case Stud…
Feat.
N. Soriano,
K. Thorp
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium
CAR T-Cell Therapy and Emerging Bispecifics for the Treatment of Fol…
Feat.
S. Ahmed
20:03
19th Annual International Ultmann Chicago Lymphoma Symposium
Biology of Follicular Lymphoma
Feat.
R. Kridel
25:29
19th Annual International Ultmann Chicago Lymphoma Symposium
Mantle Cell Lymphoma: Case-Based Approach to Management
Feat.
R. Karmali
20:13
19th Annual International Ultmann Chicago Lymphoma Symposium
Bispecific Antibodies in Lymphomas
Feat.
R. Bannerji
20:16
19th Annual International Ultmann Chicago Lymphoma Symposium
How to Sequence Non-CAR T-Cell Therapy for Relapsed DLBCL
Feat.
D. Landsburg
19:22
19th Annual International Ultmann Chicago Lymphoma Symposium
Prevention of CNS Progression in DLBCL
Feat.
C. Portell
19:28
19th Annual International Ultmann Chicago Lymphoma Symposium
Impact of the Immune Landscape on Hodgkin Lymphoma Prognosis and Tre…
Feat.
C. Steidl
19:37
19th Annual International Ultmann Chicago Lymphoma Symposium
Hodgkin Lymphoma Updates: Relapse After Auto-HCT, Brentuximab Vedoti…
Feat.
A. Sureda
42:23
19th Annual International Ultmann Chicago Lymphoma Symposium
COVID-19 in Patients With Lymphoma: Treatment Approaches, Vaccinatio…
Feat.
N. Pettit
24:15
19th Annual International Ultmann Chicago Lymphoma Symposium
Treatment of Relapsed CNS Lymphomas
Feat.
A. Ferreri
24:14
19th Annual International Ultmann Chicago Lymphoma Symposium
Prognostication and Treatment of Burkitt Lymphoma in the Modern Era
Feat.
A. Olszewski
48:49
19th Annual International Ultmann Chicago Lymphoma Symposium
Recent Advances in the Frontline Treatment of DLBCL: Is There a New …
Feat.
L. Sehn
38:14
19th Annual International Ultmann Chicago Lymphoma Symposium
Cellular Therapy in Lymphoma: Where Are We Now?
Feat.
P. Riedell
17:54
19th Annual International Ultmann Chicago Lymphoma Symposium
Debate: Auto-HCT Remains the Preferred Standard of Care for 1L Thera…
Feat.
T. Fenske
14:38
19th Annual International Ultmann Chicago Lymphoma Symposium
Debate: We Should Stop Doing Autotransplants for Patients With MCL i…
Feat.
P. Stiff
19:52
19th Annual International Ultmann Chicago Lymphoma Symposium
CLL: Present and Future
Feat.
N. Lamanna
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium
T-Cell Lymphomas: Impact of Classification on Treatment
Feat.
N. Mehta-Shah
20:39
19th Annual International Ultmann Chicago Lymphoma Symposium
Post-Acute Outcomes After HL: An Epidemiologic Perspective
Feat.
L. Morton
28:22
19th Annual International Ultmann Chicago Lymphoma Symposium
Follicular Lymphoma Management in the COVID-19 Era
Feat.
L. Gordon
41:39
19th Annual International Ultmann Chicago Lymphoma Symposium
Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…
Feat.
K. Cohen
17:53
19th Annual International Ultmann Chicago Lymphoma Symposium
Sequencing of Therapies in R/R MCL
Feat.
K. Maddocks
22:11
19th Annual International Ultmann Chicago Lymphoma Symposium
High-Grade B-Cell Lymphomas, Not Otherwise Specified: How To Differe…
Feat.
D. Scott
